Literature DB >> 33163566

Development of a Clinical Rating Scale for the Severity of Apraxia of Eyelid Opening, Either Isolated or Associated with Blepharospasm.

Gina Ferrazzano1, Antonella Muroni2, Antonella Conte1,3, Tommaso Ercoli2, Giorgio Tamburini2, Giovanni Fabbrini1,3, Alfredo Berardelli1,3, Giovanni Defazio2.   

Abstract

BACKGROUND: Apraxia of eyelid opening is a movement disorder characterized by an inability to raise the eyelids without any overt contractions of the orbicularis oculi muscle. There is currently no clinical scale to rate the severity of this condition.
OBJECTIVES: To develop and validate a novel scale that considers phenomenological aspects relevant to the severity of the condition.
METHODS: The study sample included 20 patients with apraxia of eyelid opening, either isolated (9 patients) or associated with blepharospasm (11 patients). To validate the scale, selected features were checked for reliability, reliable items were combined to generate the scale, and clinimetric properties were evaluated.
RESULTS: The novel severity scale yielded acceptable reliability, scaling assumptions, internal consistency, and sensitivity to change; a lack of floor and ceiling effects; and no correlation with the blepharospasm severity rating scale.
CONCLUSIONS: We propose a severity scale that considers the most relevant apraxia of eyelid opening motor abnormalities based on objective criteria. This scale can be reliably administered by general neurologists after a brief training.
© 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  dystonia, blepharospasm, apraxia of eyelid opening, basal ganglia, orbicularis oculi muscle spasm.

Year:  2020        PMID: 33163566      PMCID: PMC7604665          DOI: 10.1002/mdc3.13083

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  17 in total

1.  A new variant of blepharospasm.

Authors:  J S Elston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

2.  Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid opening.

Authors:  J Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

3.  Does EMG provide essential information for the diagnosis and treatment of blepharospasm?

Authors:  A Conte; G Ferrazzano; A Berardelli
Journal:  Clin Neurophysiol       Date:  2020-04-21       Impact factor: 3.708

4.  Botulinum A toxin for the so-called apraxia of lid opening.

Authors:  V Lepore; G Defazio; D Acquistapace; C Melpignano; L Pomes; P Lamberti; P Livrea; E Ferrari
Journal:  Mov Disord       Date:  1995-07       Impact factor: 10.338

Review 5.  Psychometric considerations in evaluating health-related quality of life measures.

Authors:  R D Hays; R Anderson; D Revicki
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

6.  Clinical and electromyographic features of levator palpebrae superioris muscle dysfunction in involuntary eyelid closure.

Authors:  M Aramideh; B W Ongerboer de Visser; J H Koelman; L J Bour; P P Devriese; J D Speelman
Journal:  Mov Disord       Date:  1994-07       Impact factor: 10.338

7.  "Apraxia of eyelid opening" induced by levodopa therapy and apomorphine in atypical parkinsonism (possible progressive supranuclear palsy): a case report.

Authors:  G Defazio; M De Mari; R De Salvia; P Lamberti; M Giorelli; P Livrea
Journal:  Clin Neuropharmacol       Date:  1999 Sep-Oct       Impact factor: 1.592

8.  "Apraxia" of eyelid opening: an involuntary levator inhibition.

Authors:  F E Lepore; R C Duvoisin
Journal:  Neurology       Date:  1985-03       Impact factor: 9.910

9.  Frequency of apraxia of eyelid opening in the general population and in patients with extrapyramidal disorders.

Authors:  P Lamberti; M De Mari; A Zenzola; M S Aniello; G Defazio
Journal:  Neurol Sci       Date:  2002-09       Impact factor: 3.307

10.  "Apraxia of lid opening," a focal eyelid dystonia: clinical study of 32 patients.

Authors:  P Krack; M H Marion
Journal:  Mov Disord       Date:  1994-11       Impact factor: 10.338

View more
  1 in total

1.  Diagnostic and therapeutic recommendations in adult dystonia: a joint document by the Italian Society of Neurology, the Italian Academy for the Study of Parkinson's Disease and Movement Disorders, and the Italian Network on Botulinum Toxin.

Authors:  Marcello Romano; Sergio Bagnato; Maria Concetta Altavista; Laura Avanzino; Daniele Belvisi; Matteo Bologna; Francesco Bono; Miryam Carecchio; Anna Castagna; Roberto Ceravolo; Antonella Conte; Giuseppe Cosentino; Roberto Eleopra; Tommaso Ercoli; Marcello Esposito; Giovanni Fabbrini; Gina Ferrazzano; Stefania Lalli; Marcello Maria Mascia; Maurizio Osio; Roberta Pellicciari; Simona Petrucci; Enza Maria Valente; Francesca Valentino; Mario Zappia; Maurizio Zibetti; Paolo Girlanda; Michele Tinazzi; Giovanni Defazio; Alfredo Berardelli
Journal:  Neurol Sci       Date:  2022-10-03       Impact factor: 3.830

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.